Rectum Cancer: Clinical Trials

4 trials for Rectum Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 suspended. 4 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Suspended 1
Phase 23Completed 2, Recruiting 1

Follow Rectum Cancer: new trials by email Literature Review of Rectum Cancer trials Research Report on Rectum Cancer

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer
Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamide, Fludarabine - Colorectal Cancer, Colon Cancer
Phase 1 / Phase 2RecruitingEssen Biotech852024-09-292024-11-05
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Vactosertib, Fludarabine Phosphate, Cyclophosphamide - Colorectal Cancer, Hematologic Malignancy
Phase 1SuspendedDavid Wald122022-09-092026-07-14
Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas
SGM-101 - Colon Cancer, Rectum Cancer
Phase 1 / Phase 2CompletedSurgimab752016-01-012019-07-18
Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer
Rapamycin - Rectum Cancer
Phase 1 / Phase 2CompletedMaastricht Radiation Oncology442006-09-012019-03-18

Narrower conditions

Colorectal Neoplasms (4)  ·  Rectal Neoplasms (4)  ·  Colonic Neoplasms (2)  ·  Esophageal Neoplasms (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Colonic Diseases (4)  ·  Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)  ·  Gastrointestinal Diseases (4)  ·  Gastrointestinal Neoplasms (4)  ·  Intestinal Diseases (4)  ·  Intestinal Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Rectal Diseases (4)  ·  Neoplasms (3)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)

Interventions

Cyclophosphamide (2)  ·  Interleukin-2 (2)  ·  IL32 protein, human (1)  ·  Sirolimus (1)  ·  aldesleukin (1)  ·  fludarabine (1)  ·  fludarabine phosphate (1)  ·  pembrolizumab (1)  ·  vactosertib (1)

Sponsors

David Wald (1)  ·  Essen Biotech (1)  ·  Maastricht Radiation Oncology (1)  ·  Surgimab (1)

Countries

Netherlands (2)  ·  China (1)  ·  United States (1)

Top investigators

Alexander L Vahrmeijer, MD, PhD (1)  ·  Benjamin Tomlinson, MD (1)  ·  Jeroen Buijsen, MD PhD (1)

Results publications

PMID 29361435, PMID 31960953, PMID 32416765